Antibodies act as the body’s defense system when a harmful substance enters. Antibodies, which are made by our immune system, attach to these undesirable molecules and help the body get rid of them. B cells generate antibodies (specialized white blood cells). Each antibody’s specific target is an antigen found on the invader organism. This antigen functions as a kind of key that aids the antibody in recognizing the pathogens and their toxic products. This is due to the fact that the “Y” structures at the tips of both the antibody and the antigen are identical. A B cell divides and clones as a result of coming into touch with an antigen. In our lymphatic and blood systems, these plasma cells, also called cloned B cells, release endless quantities of antibodies. In addition to our skin, lungs, tears, saliva, and even breast milk, our body also contains antibodies in other places.
Abeomics provide comprehensive monoclonal and polyclonal antibody development services starting from antigen design, peptide synthesis, and recombinant protein production. We develop monoclonal/polyclonal antibodies from synthetic peptides including phospho or acetylated peptides, recombinant proteins, gel-eluted protein, etc. Our antibodies are broadly categorized into TLR and innate immunity antibodies, Apoptosis antibodies, Immunological antibodies, Cell signaling antibodies, Infectious diseases antibodies, and others.
Biosimilars are biological products such as proteins and antibodies that are highly analogous to FDA‐approved biologic reference products and have no clinically meaningful differences in terms of safety and effectiveness from reference products. Biosimilar monoclonal antibodies are an important part of the biosimilar family that can be used in the treatment of diseases like cancer and autoimmune disorders and is also important for research use.
Abeomics provides an array of biosimilar recombinant monoclonal antibodies that include Recombinant anti-human ErbB2/HER2 Antibody (Trastuzumab), Anti-Human CD11a (Efalizumab), Anti-Human CD194 (CCR4) (Mogamulizumab) and many more.
Description | Catalog Number |
Recombinant anti- human ErbB2/HER2 Antibody (Trastuzumab) | 10-2002 |
Anti-PD-1(Opdivo)(Nivolumab biosimilar) mAb | 12-2001 |
Anti-IL-17A (Taltz) (Ixekizumab biosimilar) mAb | 12-2002 |
Anti-IL-23 (Tremfya)(Guselkumab biosimilar) mAb | 12-2003 |
Anti-Human HER-2 (Trastuzumab) | 12-8001 |
Anti-Human HER-2 (Trastuzumab) APC | 12-8002 |
Anti-Human HER-2 (Trastuzumab) Biotin | 12-8003 |
Anti-Human HER-2 (Trastuzumab) Dylight® 488 | 12-8004 |
Anti-Human HER-2 (Trastuzumab) HRP | 12-8005 |
Anti-Human HER-2 (Trastuzumab) PE | 12-8006 |
Anti-Human HER-2 (Trastuzumab) Fc Muted | 12-8007 |
Anti-Human HER-2 (Trastuzumab) Fc Muted Biotin | 12-8008 |
Anti-Human HER-2 (Trastuzumab) Fc Muted Biotin | 12-8009 |
Anti-Human CD11a (Efalizumab) | 12-8010 |
Anti-Human CD11a (Efalizumab) APC | 12-8011 |
Anti-Human CD11a (Efalizumab) Biotin | 12-8012 |
Anti-Human CD11a (Efalizumab) Dylight® 488 | 12-8013 |
Anti-Human CD11a (Efalizumab) HRP | 12-8014 |
Anti-Human CD11a (Efalizumab) PE | 12-8015 |
Anti-Human CD11a (Efalizumab) Fc Muted | 12-8016 |
Anti-Human CD11a (Efalizumab) Fc Muted Biotin | 12-8017 |
Anti-Human CD11a (Efalizumab) Fc Muted HRP | 12-8018 |
Anti-Human CD194 (CCR4) (Mogamulizumab) | 12-8019 |
Anti-Human CD194 (CCR4) (Mogamulizumab) Biotin | 12-8020 |
Anti-Human CD194 (CCR4) (Mogamulizumab) HRP | 12-8021 |
Anti-Human CD194 (CCR4) (Mogamulizumab) Fc Muted | 12-8022 |
Anti-Human CD194 (CCR4) (Mogamulizumab) Fc Muted Biotin | 12-8023 |
nti-Human CD194 (CCR4) (Mogamulizumab) Fc Muted HRP | 12-8024 |
Anti-Human CD20 (Rituximab) | 12-8025 |
Anti-Human CD20 (Rituximab) Dylight® 488 | 12-8026 |
Anti-Human CD20 (Rituximab) PE | 12-8027 |
Anti-Human CD20 (Rituximab) APC | 12-8028 |
Anti-Human CD20 (Rituximab) Fc Muted | 12-8029 |
Anti-Human CD257 (BAFF) (Tabalumab) | 12-8030 |
Anti-Human CD257 (BAFF) (Tabalumab) Biotin | 12-8031 |
Anti-Human CD257 (BAFF) (Tabalumab) Dylight® 488 | 12-8032 |
Anti-Human CD257 (BAFF) (Tabalumab) PE | 12-8033 |
Anti-Human CD257 (BAFF) (Tabalumab) Fc Muted | 12-8034 |
Anti-Human CD257 (BAFF) (Tabalumab) Fc Muted Biotin | 12-8035 |
Anti-Human CD257 (BAFF) (Tabalumab) Fc Muted HRP | 12-8036 |
Anti-Human CD279 (PD-1) (Nivolumab) | 12-8037 |
Anti-Human CD279 (PD-1) (Nivolumab) APC | 12-8038 |
Anti-Human CD279 (PD-1) (Nivolumab) Dylight® 488 | 12-8039 |
Anti-Human CD279 (PD-1) (Nivolumab) PE | 12-8040 |
Anti-Human CD279 (PD-1) (Nivolumab) Fc Muted | 12-8041 |
Anti-Human CD49D (Integrin alpha 4) (Natalizumab) | 12-8042 |
Anti-Human CD49D (Integrin alpha 4) (Natalizumab) APC | 12-8043 |
Anti-Human CD49D (Integrin alpha 4) (Natalizumab) Dylight® 488 | 12-8044 |
Anti-Human CD49D (Integrin alpha 4) (Natalizumab) PE | 12-8045 |
Anti-Human CD49D (Integrin alpha 4) (Natalizumab) Fc Muted | 12-8046 |
Anti-Human CD52 (Alemtuzumab) | 12-8047 |
Anti-Human CD52 (Alemtuzumab) APC | 12-8048 |
Anti-Human CD52 (Alemtuzumab) Biotin | 12-8049 |
Anti-Human CD52 (Alemtuzumab) HRP | 12-8050 |
Anti-Human CD52 (Alemtuzumab) PE | 12-8051 |
Anti-Human CD52 (Alemtuzumab) Fc Muted | 12-8052 |
Anti-Human CD52 (Alemtuzumab) Fc Muted HRP | 12-8053 |
Anti-Human CTLA-4 (Ipilimumab) | 12-8054 |
Anti-Human CTLA-4 (Ipilimumab) Biotin | 12-8055 |
Anti-Human CTLA-4 (Ipilimumab) HRP | 12-8056 |
Anti-Human CTLA-4 (Ipilimumab) Fc Muted | 12-8057 |
Anti-Human CTLA-4 (Ipilimumab) Fc Muted Biotin | 12-8058 |
Anti-Human CTLA-4 (Ipilimumab) Fc Muted HRP | 12-8059 |
Anti-Human DR5 (Drozitumab) | 12-8060 |
Anti-Human DR5 (Drozitumab) APC | 12-8061 |
Anti-Human DR5 (Drozitumab) Dylight® 488 | 12-8062 |
Anti-Human DR5 (Drozitumab) HRP | 12-8063 |
Anti-Human DR5 (Drozitumab) PE | 12-8064 |
Anti-Human DR5 (Drozitumab) Fc Muted | 12-8065 |
Anti-Human DR5 (Drozitumab) Fc Muted Biotin | 12-8066 |
Anti-Human DR5 (Drozitumab) Fc Muted HRP | 12-8067 |
Anti-Human EGFR (Cetuximab) | 12-8068 |
Anti-Human EGFR (Cetuximab) Fc Muted | 12-8069 |
Anti-Human IL 12/23 (Briakinumab) | 12-8070 |
Anti-Human IL 12/23 (Briakinumab) APC | 12-8071 |
Anti-Human IL 12/23 (Briakinumab) Biotin | 12-8072 |
Anti-Human IL 12/23 (Briakinumab) HRP | 12-8073 |
Anti-Human IL 12/23 (Briakinumab) PE | 12-8074 |
Anti-Human IL 12/23 (Briakinumab) Dylight® 488 | 12-8075 |
Anti-Human IL 12/23 (Briakinumab) Fc Muted | 12-8076 |
Anti-Human IL 12/23 (Briakinumab) Fc Muted Biotin | 12-8077 |
Anti-Human IL 12/23 (Briakinumab) Fc Muted HRP | 12-8078 |
Anti-Human IL-2R alpha (CD25) (Basiliximab) | 12-8079 |
Anti-Human IL-2R alpha (CD25) (Basiliximab) APC | 12-8080 |
Anti-Human IL-2R alpha (CD25) (Basiliximab) Dylight® 488 | 12-8081 |
Anti-Human IL-2R alpha (CD25) (Basiliximab) PE | 12-8082 |
Anti-Human IL-2R alpha (CD25) (Basiliximab) Fc Muted | 12-8083 |
Anti-Human IL-6 (Sarilumab) | 12-8084 |
Anti-Human IL-6 (Sarilumab) APC | 12-8085 |
Anti-Human IL-6 (Sarilumab) Biotin | 12-8086 |
Anti-Human IL-6 (Sarilumab) Biotin | 12-8087 |
Anti-Human IL-6 (Sarilumab) PE | 12-8088 |
Anti-Human IL-6 (Sarilumab) Dylight® 488 | 12-8089 |
Anti-Human IL-6 (Sarilumab) Fc Muted | 12-8090 |
Anti-Human IL-6 (Sarilumab) Fc Muted Biotin | 12-8091 |
Anti-Human IL-6 (Sarilumab) Fc Muted HRP | 12-8092 |
Anti-Human OX40L (Oxelumab) | 12-8093 |
Anti-Human OX40L (Oxelumab) APC | 12-8094 |
Anti-Human OX40L (Oxelumab) Dylight® 488 | 12-8095 |
Anti-Human OX40L (Oxelumab) PE | 12-8096 |
Anti-Human OX40L (Oxelumab) Fc Muted | 12-8097 |
Anti-Human TNF alpha (Adalimumab)clone D2E7 | 12-8098 |
Anti-Human TNF alpha (Adalimumab) APC | 12-8099 |
Anti-Human TNF alpha (Adalimumab) Biotin | 12-8100 |
Anti-Human TNF alpha (Adalimumab) Dylight 488® | 12-8101 |
Anti-Human TNF alpha (Adalimumab) HRP | 12-8102 |
Anti-Human TNF alpha (Adalimumab) PE | 12-8103 |
Anti-Human TNF alpha (Adalimumab) Fc Muted | 12-8104 |
Anti-Human TNF alpha (Adalimumab) Fc Muted Biotin | 12-8105 |
Anti-Human TNF alpha (Adalimumab) Fc Muted HRP | 12-8106 |
Anti-Human VEGF (Bevacizumab) | 12-8107 |
Anti-Human VEGF (Bevacizumab) Biotin | 12-8108 |
Anti-Human VEGF (Bevacizumab) HRP | 12-8109 |
Anti-Human VEGF (Bevacizumab) Fc Muted | 12-8110 |
Anti-Human VEGF (Bevacizumab) Fc Muted Biotin | 12-8111 |
Anti-Human VEGF (Bevacizumab) Fc Muted HRP | 12-8112 |
Anti-CD47 Antibody (magrolimab biosimilar) (Hu5F9-G4) | 12-9061 |
Anti-CS1 Antibody (elotuzumab biosimilar) (HuLuc63) | 12-9062 |
Anti-CD123 Antibody (talacotuzumab biosimilar) (CSL362) | 12-9063 |
Anti-CD38 Antibody (daratumumab biosimilar) (HuMax-CD38) | 12-9064 |
Anti-CD70 Antibody (vorsetuzumab biosimilar) (SGN-70) | 12-9065 |
Anti-PD-1 Antibody (pembrolizumab biosimilar) (MK-3475) | 12-9066 |
Anti-IL6 Antibody (siltuximab biosimilar) (CLLB8) | 12-9067 |
Anti-TIM3 Antibody (cobolimab biosimilar) (TSR-022) | 12-9068 |
Anti-PDL1 Antibody (atezolizumab biosimilar) (RG7446) | 12-9069 |
Anti-B7-H3 Antibody (enoblituzumab biosimilar) (MGA271) | 12-9070 |
Anti-SARS-CoV-2 Antibody (CB6) | 12-9071 |
Anti-ICOS Antibody (vopratelimab biosimilar) (JTX-2011) | 12-9072 |
Anti-SARS-CoV Antibody (CR3022) | 12-9073 |
Anti-CD138 Antibody (indatuximab ravtansine biosimilar) (BT062) | 12-9074 |
Anti-CD33 Antibody (gemtuzumab ozogamicin biosimilar) (CDP-771) | 12-9075 |
Anti-BCMA Antibody (HuC11D5.3) | 12-9076 |
Anti-CD30 Antibody (brentuximab vedotin biosimilar) (SGN-35) | 12-9077 |
Anti-CD27 Antibody (varlilumab biosimilar) (1F5) | 12-9078 |
Anti-EPHA3 Antibody (ifabotuzumab biosimilar) (KB004) | 12-9079 |
Anti-CD40 Antibody (iscalimab biosimilar)(CFZ-533) | 12-9080 |
Anti-Mesothelin Antibody (amatuximab biosimilar) (MORAb-009) | 12-9081 |
Anti-CTLA4 Antibody (ipilimumab biosimilar) (MDX-CTLA-4) | 12-9082 |
Anti-Trop2 Antibody (sacituzumab govitecan biosimilar) (IMMU-132) | 12-9083 |
Anti-TIGIT Antibody (etigilimab biosimilar) (OMP-313M32) | 12-9084 |
Anti-CD20 (rituximab biosimilar) (MS4A1) | 12-9085 |
Anti-TIGIT Antibody (tiragolumab biosimilar) (MTIG-7192-A) | 12-9086 |
Anti-TIGIT Antibody ((vibostolimab biosimilar) (MK-7684) | 12-9087 |
Anti-BCMA Antibody (belantamab biosimilar) (J6M0) | 12-9088 |
Anti-CD22 Antibody (pinatuzumab biosimilar) (FCU2803) | 12-9089 |
Anti-CD52 Antibody (alemtuzumab biosimilar) (Campath-1H) | 12-9090 |
Anti-TweakR Antibody (enavatuzumab biosimilar) (PDL 192) | 12-9091 |
Anti-TNFRSF10B Antibody (tigatuzumab biosimilar) (GEN-1029) | 12-9092 |
Anti-AXL Antibody (enapotamab biosimilar) (HuMax-AXL-ADC) | 12-9093 |
Anti-EGFR Antibody (Cetuximab biosimilar) (Fab C225) | 12-9094 |
Anti-CEACAM5 Antibody (labetuzumab biosimilar) (IMMU-130) | 12-9095 |
Anti-ICAM1 Antibody (bersanlimab biosimilar) (BI-505) | 12-9096 |
Anti-4-1BB Antibody (utomilumab biosimilar) (PF-2566) | 12-9097 |
Anti-IL17RA Antibody (brodalumab biosimilar) (AMG827) | 12-9098 |
Anti-NKG2D Antibody (tesnatilimab biosimilar) (JNJ-64304500) | 12-9099 |
Anti-CA9 Antibody (girentuximab biosimilar) (WX-G250) | 12-9100 |
Anti-IL6R Antibody (tocilizumab biosimilar) (MRA) | 12-9101 |
Anti-CD40L Antibody (ruplizumab biosimilar) (hu5c8) | 12-9102 |
Anti-IL2RA Antibody (basiliximab biosimilar) (CHI621) | 12-9103 |
Anti-BAFF Antibody (belimumab biosimilar) (LymphoStat-B) | 12-9104 |
Anti-BAFFR Antibody (ianalumab biosimilar) (VAY-736) | 12-9105 |
Anti-CD37 Antibody(naratuximab biosimilar) (IMGN-529) | 12-9106 |
Anti-CCR8 antibody(DM197), Rabbit mAb | 12-9107 |
Anti-CCR8 antibody(DM196), Rabbit mAb | 12-9108 |
Anti-CCR8 antibody(DM195), Rabbit mAb | 12-9109 |
Anti-CCR8 antibody(DM180), Rabbit mAb | 12-9110 |
Recombinant anti-human-IL-1 beta Antibody (Canakinumab Biosimilar) | 12-9112 |
Anti-ERBB2 (trastuzumab biosimilar) mAb | 12-9113 |
Anti-CD47 (magrolimab biosimilar) mAb | 12-9115 |
Anti-CD19 (inebilizumab biosimilar) mAb | 12-9116 |
Anti-IL-4RA (dupilumab biosimilar) mAb | 12-9117 |
Anti-OX40 (ivuxolimab biosimilar) mAb | 12-9118 |
Anti-BTLA (icatolimab biosimilar) mAb | 12-9119 |
Anti-CSF1R (cabiralizumab biosimilar) mAb | 12-9120 |
Anti-TNFa (Adalimumab biosimilar) mAb | 12-9121 |
Anti-HER3 (patritumab biosimilar) mAb | 12-9122 |
Anti-TNFSF11 (denosumab biosimilar) mAb | 12-9123 |
Anti-VEGFR2 (ramucirumab biosimilar) mAb | 12-9124 |
Anti-VEGFA (bevacizumab biosimiar) mAb | 12-9125 |
Anti-LAG3 (relatlimab biosimilar) mAb | 12-9126 |
Anti-ADAM9 mAb | 12-9127 |
Anti-GITR/TNFRSF18 (ragifilimab) mAb | 12-9128 |
Anti-GUCY2C (indusatumab biosimilar) mAb | 12-9129 |
Anti-DLL3 (Rovalpituzumab Tesirine biosimilar) mAb | 12-9130 |
Anti-GPRC5D (Talquetamab biosimilar) mAb | 12-9131 |
Anti-ROR1 (zilovertamab biosimilar) mAb | 12-9132 |
Anti-ITGA4 (natalizumab biosimilar) mAb | 12-9133 |
Anti-CLDN18.2 (zolbetuximab biosimilar) | 12-9134 |
Anti-CD47 (lemzoparlimab biosimilar) mAb | 12-9135 |
Anti-SELP (crizanlizumab biosimilar) mAb | 12-9136 |
Anti-B7-H4 (alsevalimab biosimilar) mAb | 12-9137 |
Anti-TSHR (M22) mAb | 12-9138 |
Anti-TSHR (K1-70) mAb | 12-9139 |
Anti-IFNAR1(anifrolumab biosimilar) mAb | 12-9140 |
Anti-MST1R(narnatumab biosimilar) mAb | 12-9141 |
Anti-NRP1(vesencumab biosimilar) mAb | 12-9142 |
Anti-C5AR1(avdoralimab biosimilar) mAb | 12-9143 |
Anti-IL9(enokizumab biosimilar) mAb | 12-9144 |
Anti-F3(tisotumab biosimilar) mAb | 12-9145 |
Anti-CCL2(carlumab biosimilar) mAb | 12-9146 |
Anti-SSTR2(tidutamab biosimilar) mAb | 12-9147 |
Anti-PSMA(rosopatamab biosimilar) mAb | 12-9148 |
Anti-CD73(uliledlimab biosimilar) mAb | 12-9149 |
Anti-GM-CSF(plonmarlimab biosimilar) mAb | 12-9150 |
Anti-FLT1(icrucumab biosimilar) mAb | 12-9151 |
Anti-IL20(fletikumab biosimilar) mAb | 12-9152 |
Anti-CXCL10(eldelumab biosimilar) mAb | 12-9153 |
Anti-KIR2DL2(lirilumab biosimilar) mAb | 12-9154 |
Anti-APP(aducanumab biosimilar) mAb | 12-9155 |
Anti-IL17A (Cosentyx) (secukinumab biosimilar) mAb | 12-9156 |
Anti-TFRC(pabinafusp alfa biosimilar) mAb | 12-9157 |
Anti-IFNG(emapalumab biosimilar) mAb | 12-9158 |
Anti-GCGR(volagidemab biosimilar) mAb | 12-9159 |
Anti-IL13(tralokinumab biosimilar) mAb |
12-9160 |
Anti-LILRB2 (MK-4830) mAb | 12-9161 |
Anti-GPC3(Hu9F2) mAb | 12-9162 |
Anti-OSMR(vixarelimab biosimilar) mAb | 12-9163 |
Anti-HTRA1(galegenimab biosimilar) mAb | 12-9164 |
Anti-GP6(glenzocimab biosimilar) mAb | 12-9165 |
Anti-ENPP3(Xencor) mAb | 12-9166 |
Anti-BTN3A1(ICT 01) mAb | 12-9167 |
Anti-PDL1 (durvalumab biosimilar) mAb | 12-9168 |
Anti-CD26 (begelomab biosimilar) mAb | 12-9169 |
Anti-CLEC4C (litifilimab biosimilar) mAb | 12-9170 |
Anti-B7-H2(prezalumab biosimilar) mAb | 12-9172 |
Anti-CLDN6 (IMAB027) mAb | 12-9173 |
Anti-GPC3(codrituzumab biosimilar) mAb | 12-9174 |
Anti-IL7RA(lusvertikimab biosimilar) mAb | 12-9175 |
Anti-NKG2A(monalizumab biosimilar) mAb | 12-9176 |
Anti-CCR4(mogamulizumab biosimilar) mAb | 12-9177 |
Anti-CCR2(plozalizumab biosimilar) mAb | 12-9178 |
Anti-Nectin-4(enfortumab biosimilar) mAb | 12-9179 |
Anti-FCRL5(cevostamab biosimilar without anti-CD3 portion) mAb | 12-9180 |
Anti-GDF15(ponsegromab biosimilar) mAb | 12-9181 |
Anti-GFRA3(nadecnemab biosimilar) mAb | 12-9182 |
Anti-CD19(FMC63 biosimilar) mAb | 12-9183 |
Anti-PCSK9(bococizumab biosimilar) mAb | 12-9184 |
Anti-IL1A(bermekimab biosimilar) mAb | 12-9185 |
Anti-MIF(imalumab biosimilar) mAb | 12-9186 |
Anti-NOTCH3(tarextumab biosimilar) mAb | 12-9187 |
Anti-CEACAM6(tinurilimab biosimilar) mAb | 12-9188 |
Anti-CXCR4(ulocuplumab biosimilar) mAb | 12-9189 |
Anti-CD56(lorvotuzumab biosimilar) mAb | 12-9190 |
Anti-IL21(avizakimab biosimilar) mAb | 12-9191 |
Anti-M-CSF(lacnotuzumab biosimilar) mAb | 12-9192 |
Anti-CCN2(pamrevlumab biosimilar) mAb | 12-9193 |
Anti-AMHR2(murlentamab biosimilar) mAb | 12-9194 |
Anti-DKK1(sirexatamab biosimilar) mAb | 12-9195 |
Anti-B7-H5(onvatilimab biosimilar) mAb | 12-9196 |
Anti-TSLP(tezepelumab biosimilar) mAb | 12-9197 |
Anti-LIV-1(ladiratuzumab biosimilar) mAb | 12-9198 |
Anti-IL22(fezakinumab biosimilar) mAb | 12-9199 |
Anti-CCR8(BMS 986340) mAb | 12-9200 |
Toll-like receptors (TLRs) belong to a class of pattern recognition receptors (PRRs) that constitute the first line of defense system against pathogenic microbes. TLRs recognize both the external pathogen-associated molecular patterns (PAMPs) derived from various microbes and endogenous self-derived molecules from damaged cells, damage-associated molecular patterns (DAMPs). TLRs play a crucial role in innate immunity by initiating signal transduction pathways, leading to activation of the transcription factors NF-kB and IRFs and expression of cytokines, chemokines, and type I IFNs genes. TLRs comprise a family of type I transmembrane receptors that contain three structural domains: an extracellular LRR (Leucine-Rich Repeat) domain, a transmembrane domain and an intracellular Toll/IL-1 receptor (TIR) domain. TLRs are expressed in both innate immune cells like macrophages and dendritic cells, and in non-immune cells including fibroblast cells and epithelial cells. In humans, 10 TLRs have been identified (TLR1–TLR10) in comparison to mouse where 13 TLRs (TLR1–TLR13) have been identified till now.
Abeomics have developed several TLR antibodies including antibodies to TLR6, TLR9, TLR3, TLR4, TLR8, TLR5, and other proteins of TLR pathways.
Description | Catalog Number |
Monoclonal Antibody to TLR6 (Clone: ABM1B50) | 10-3002 |
Monoclonal Antibody to TLR6 (Clone: ABM1B50)-FITC Conjugated | 10-3002-F |
NALE™ Monoclonal Antibody to TLR6 (Clone: ABM1B50) | 10-3002-NALE |
Monoclonal Antibody to TLR9 (Clone: ABM1C51) | 10-3003 |
Monoclonal Antibody to TLR9 (Clone: ABM1C51) FITC conjugated | 10-3003-F |
NALE™ Monoclonal Antibody to TLR9 (Clone: ABM1C51) | 10-3003-NALE |
Monoclonal Antibody to TLR9 (Clone: ABM1C51) PE conjugated | 10-3003-P |
Monoclonal Antibody to TLR3 (Clone: ABM15D5) | 10-3004 |
Monoclonal Antibody to TLR3 (Clone: ABM15D5)-FITC conjugated | 10-3004-F |
Monoclonal Antibody to TLR3 (Clone: ABM15D5)-PE conjugated | 10-3004-P |
Monoclonal Antibody to TLR8/CD288 (Clone: ABM15F6) | 10-3005 |
Monoclonal Antibody to TLR8/CD288 FITC Conjugated (Clone: ABM15F6) | 10-3005-F |
NALE™ Monoclonal Antibody to TLR8/CD288 (Clone: ABM15F6) | 10-3005-NALE |
Anti-PGRP-S Monoclonal Antibody (Clone: ABM17E7) | 10-3007 |
Anti-PGRP-1b Monoclonal Antibody (Clone: ABM18D7) | 10-3008 |
Monoclonal Antibody to TLR4 / CD284 (Clone: ABM19C4) | 10-3010 |
Monoclonal Antibody to TLR4 / CD284 (Clone: ABM19C4) FITC Conjugated | 10-3010-F |
NALE™ Monoclonal Antibody to TLR4 (Clone: ABM19C4) | 10-3010-NALE |
Monoclonal antibody to MyD88 (Clone: ABM2H20) | 10-3012 |
Monoclonal antibody to MyD88 (Clone: ABM2H20) FITC Conjugated | 10-3012-F |
Monoclonal Antibody to TLR5 (Clone: ABM22G1) | 10-3013 |
Monoclonal Antibody to TLR5 (Clone: ABM22G1) FITC conjugated | 10-3013-F |
NALE™ Monoclonal Antibody to TLR5 (Clone: ABM22G1) | 10-3013-NALE |
Monoclonal antibody to TLR5 (Clone: ABM22C2) | 10-3014 |
Monoclonal Antibody to TLR7 (Clone: ABM2C27) | 10-3015 |
Monoclonal antibody to TLR7 (Clone: ABM2C27) FITC Conjugated | 10-3015-F |
NALE™ Monoclonal Antibody to TLR7 (Clone: ABM2C27) | 10-3015-NALE |
Monoclonal Antibody to Mouse TLR3 (Clone: ABM24E5) | 10-3017 |
Monoclonal Antibody to NALP3 (Clone: ABM2D48) | 10-3018 |
Monoclonal Antibody to TLR4 (Clone: HTA125) | 10-3021 |
Monoclonal Antibody to TLR4 (Clone: HTA125) APC Conjugated | 10-3021-AC |
Monoclonal Antibody to TLR4 (Clone: HTA125) PE Conjugated | 10-3021-P |
Monoclonal antibody to Mouse TLR4 CD284 (Clone: MTS510) | 10-3022 |
Monoclonal antibody to Mouse TLR4 CD284 (Clone: MTS510) FITC Conjugated | 10-3022-F |
Monoclonal Antibody to TLR10 (Clone: ABM3C85) | 10-3024 |
Monoclonal Antibody to TLR2 (Clone: ABM3A87) | 10-3026 |
Monoclonal Antibody to TLR2 (Clone: ABM3A87) APC conjugated | 10-3026-AC |
Monoclonal Antibody to TLR2 (Clone: ABM3A87) FITC conjugated | 10-3026-F |
NALE™ Monoclonal Antibody to TLR2 (Clone: ABM3A87) | 10-3026-NALE |
Monoclonal Antibody to TLR2 (Clone: ABM3A87) PE conjugated | 10-3026-P |
Monoclonal Antibody to EPS8 (Clone: ABM4H15) | 10-3028 |
Monoclonal Antibody to Mouse TLR9 (Clone: ABM4D70 | 10-3029 |
Monoclonal Antibody to Mouse TLR9 (Clone: ABM4D70) FITC Conjugated | 10-3029-F |
NALE™ Monoclonal Antibody to Mouse TLR9 (Clone: ABM4D70) (No Azide Low Endotoxin) | 10-3029-NALE |
Monoclonal Antibody to Mouse TLR9 (Clone: ABM4D70) PE conjugated | 10-3029-P |
Anti Mouse TLR7 Monoclonal Antibody (Clone: ABM48D1) | 10-3030 |
Polyclonal Antibody to ST2 | 11-3002 |
Polyclonal Antibody to UNC93B | 11-3004 |
Polyclonal Antibody to NALP2 | 11-3008 |
Polyclonal Antibody to USP7 | 11-3009 |
Polyclonal Antibody to NALP10 | 11-3011 |
Polyclonal Antibody to DUBA | 11-3014 |
Polyclonal Antibody to MyD88 | 11-3015 |
Polyclonal Antibody to TRIL | 11-3020 |
Polyclonal Antibody to TxNIP/VDUP1 | 11-3023 |
Polyclonal Antibody to NALP3 | 11-3024 |
Polyclonal Antibody to mTLR3 | 11-3025 |
Polyclonal Antibody to Cactin | 11-3026 |
Polyclonal Antibody to IMPDHII | 11-3028 |
Polyclonal Antibody to IMPDHII | 11-3029 |
Polyclonal Antibody to Viperin | 11-3030 |
Polyclonal Antibody to Gbp1 | 11-3031 |
Polyclonal Antibody to AIMP1 | 11-3035 |
Polyclonal Antibody to Mouse TLR9 | 11-3036 |
Polyclonal Antibody to Mouse TLR4 | 11-3039 |
Polyclonal Antibody to HMGB1 | 11-3040 |
Polyclonal Antibody to TLR1 | 11-3041 |
Polyclonal Antibody to NALP2 | 11-3044 |
Polyclonal Antibody to HMGB1 | 11-3045 |
Polyclonal Antibody to IRAK2 | 11-3046 |
Polyclonal Antibody to h TLR5 | 11-3047 |
Anti-TLR4 Polyclonal Antibody | 39-2114 |
Apoptosis is the process by which a cell stops dividing and growing and instead begins a process that eventually leads to the cell’s controlled death without releasing its contents into the surrounding environment. Together with several enzyme-dependent biochemical processes, apoptosis is characterised by variety of distinctive morphological changes in the cell’s structure. Apoptosis is a potentially complex process with several signalling pathways. With apoptosis at the forefront of study, scientists are able to create promising treatment approaches that centre on the voluntary death of abnormal cells. Monoclonal antibodies are desirable therapeutic possibilities due to their ability for disease-specific targeting and low toxicity profiles. By causing target cell-specific death or altering anti-apoptotic signalling pathways, monoclonal antibodies alone may make target cells more susceptible to chemotherapeutic or radiotherapeutic treatments, depending on their mode of action. Abeomics has developed cutting-edge technologies that have been used to build precision antibody such as DR4, NOXA, 14-3-3, TRAM, Caspase-3, Catalase, Caspase-1 etc.
Immunology is specifically the area of biology that deals with the immune system’s construction and operation, the physical separation of self and non-self, and the application of antibody-based laboratory methods or immunoassays. The two primary forms of defense are innate and adaptive immune responses, the latter of which is composed of cell-mediated and antibody-mediated responses. The innate immune system serves as the body’s initial line of defense against infection. It has some selectivity for microorganisms, activates the acute inflammatory response, and operates quickly but it has no memory. The adaptive immune system, in contrast, takes more time to mature, is extremely specialized, and retains the memory of earlier microbial encounters. Monoclonal antibodies can be used to identify surface molecules on a variety of immune cells and other tissues, which is crucial for the separation, characterization, and classification of immune cells as well as the investigation of the structure and function of diverse membrane surface molecules.
Abeomics offer several immunological antibodies that include both monoclonal and polyclonal antibodies like TIM-3, CD3, CD26, STING, NR2F6, RAGE, and many more.
DNA methylation is an epigenetic process that involves the addition of methyl groups to the DNA molecule at many different sites and alters the gene expression by producing lethal and mutagenic lesions. DNA methylation regulates gene expression by the recruitment of proteins involved in gene expression or inhibiting the transcription factors that bind to the DNA. Epigenetic mechanisms like DNA methylation are reversible processes and their inhibition plays a role in the repair of double-strand breaks, the most detrimental type of DNA damage. When damaged DNA is repaired, epigenetic markers are also reconstructed. DNA methylation is believed to be more resilient than other epigenetic markers and aids in maintaining alterations in gene expression. A DNA methylation antibody aids researchers in their understanding of DNA methylation and how illnesses, cell cycle control, and embryonic development are affected by it.
Abeomics Inc. offers well-characterized DNA methylation antibodies that may help scientists and researchers better understand the role of aberrant DNA methylation in diseases like cancer, atherosclerosis, cardiovascular diseases, and nervous disorders. Major methylation antibodies include DNMT3b, DNMT3a, MBD1, MLH1, PMS2 etc.
Description | Catalog |
Monoclonal Antibody to DNMT3b (Clone:ABM1C25 ) | 10-7001 |
Monoclonal Antibody to Dnmt1 (Clone: ABM13B2) | 10-7002 |
Monoclonal Antibody to DNMT3a (Clone: ABM13G4 ) | 10-7003 |
Monoclonal Antibody to DNMT3a (Clone: ABM13G4 ) FITC Conjugated | 10-7003-F |
Monoclonal Antibody to DNMT3a (Clone: ABM1F35) | 10-7004 |
Monoclonal Antibody to DNMT3a (Clone: ABM1F35) FITC Conjugated | 10-7004-F |
Monoclonal Antibody to MBD2/MBD3 (Clone: ABM14A8) | 10-7006 |
Monoclonal Antibody to MBD1 (Clone: ABM15H2) | 10-7007 |
Monoclonal Antibody to MBD1 (Clone: ABM15H2) FITC Conjugated | 10-7007-F |
Monoclonal Antibody to DNMT2 (Clone: ABM1H70) | 10-7010 |
Monoclonal Antibody to MLH1 (Clone:ABM17C1) | 10-7011 |
Monoclonal Antibody to PMS2 (Clone: ABM17G4) | 10-7012 |
Polyclonal Antibody to ICAD | 11-7002 |
Polyclonal Antibody to LSD1 | 11-7004 |
Polyclonal Antibody to DMAP1 | 11-7005 |
Polyclonal Antibody to Histone H3.3 | 11-7007 |
Polyclonal Antibody to Furin | 11-7008 |
Polyclonal Antibody to Histone H2A.x | 11-7010 |
Polyclonal Antibody to Histone H2A.x | 11-7011 |
Polyclonal Antibody to Dnmt3L | 11-7014 |
Polyclonal Antibody to HMGN1/HMG14 | 11-7016 |
Polyclonal Antibody to Histone H2A | 11-7017 |
Polyclonal Antibody to PRMT7 | 11-7018 |
Polyclonal Antibody to DDB1 | 11-7031 |
Polyclonal Antibody to PRDM5 | 11-7032 |
Polyclonal Antibody to eIF3A | 11-7033 |
Polyclonal Antibody to SMC4 | 11-7034 |
Polyclonal Antibody to HDAC11 | 11-7035 |
Polyclonal Antibody to SETD7 | 11-7036 |
Polyclonal antibody to MTA2 | 11-7037 |
Polyclonal antibody to eIF4B | 11-7038 |
Polyclonal antibody to JMJD6 | 11-7040 |
Phospho-Histone H3 (Ser28) (Clone: D6) rabbit mAb | 12-4046 |
Phospho-Histone H3 (Ser28) (Clone: D6) rabbit mAb PE conjugate | 12-4047 |
Phospho-Histone H3 (Ser28) (Clone: D6) rabbit mAb FITC conjugate | 12-4048 |
Phospho-Histone H3 (Ser28) (Clone: D6) rabbit mAb APC conjugate | 12-4049 |
Phospho-Histone H3 (Ser10) (Clone: 4B6) rabbit mAb | 12-4054 |
Phospho-Histone H3 (Ser10) (Clone: 4B6) rabbit mAb PE conjugate | 12-4055 |
Phospho-Histone H3 (Ser10) (Clone: 4B6) rabbit mAb APC conjugate | 12-4056 |
Phospho-Histone H2A.X (Ser139) (Clone: 1B3) rabbit mAb | 12-4094 |
Phospho-Histone H2A.X (Ser139) (Clone: 1E4) rabbit mAb | 12-4115 |
Phospho-Histone H3 (Ser10) (Clone: 4B6) rabbit mAb FITC conjugate | 12-4155 |
Phospho-Histone H3 (Ser10) (Clone: 4B6) rabbit mAb SureLight conjugate | 12-4156 |
Phospho-Histone H2A.X (Ser139) (Clone: 1B3) rabbit mAb PE conjugate | 12-4206 |
Phospho-Histone H2A.X (Ser139) (Clone: 1B3) rabbit mAb APC conjugate | 12-4207 |
Phospho-Histone H2A.X (Ser139) (Clone: 1E4) rabbit mAb PE conjugate | 12-4213 |
Phospho-Histone H2A.X (Ser139) (Clone: 1E4) rabbit mAb FITC conjugate | 12-4214 |
Phospho-Histone H2A.X (Ser139) (Clone: 1E4) rabbit mAb APC conjugate | 12-4215 |
Phospho-Histone H2A.X (Ser139) (Clone: 1E4) rabbit mAb SureLight 488 conjugate | 12-4216 |
Cleaved PARP (Asp214) (Clone: H8) rabbit mAb | 12-4264 |
Cleaved PARP (Asp214) (Clone: H8) rabbit mAb PE conjugate | 12-4265 |
Cleaved PARP (Asp214) (Clone: H8) rabbit mAb FITC conjugate | 12-4266 |
Cleaved PARP (Asp214) (Clone: H8) rabbit mAb APC conjugate | 12-4267 |
Anti-HDAC6 Antibody (Clone : 2H3) | 30-2523 |
Anti-HDAC6 Antibody (Clone : 3D2) | 30-2524 |
Anti-HDAC6 Antibody (Clone : 159) | 30-2525 |
Anti-HDAC6 Antibody (Clone : 178) | 30-2526 |
Anti-HDAC6 Antibody (Clone : 236) | 30-2527 |
Monoclonal Antibody to Fibrillarin/Nop1p (Clone: 38F3) | 34-1031 |
Monoclonal Antibody to Lys20p and Lys21p (Clone: 31F5) | 34-1056 |
Polyclonal Antibody to Lamin A/C | 34-1057 |
Monoclonal Antibody to Lamin A/C (Clone: 4C4) | 34-1058 |
Monoclonal Antibody to Pdi1p (Clone: 38H8) | 34-1098 |
Monoclonal Antibody to Tar DNA binding protein 43(Clone: 3H8) | 34-1114 |
Monoclonal Antibody to TAF-15(Clone: 4D71 ) | 34-1115 |
Polyclonal Antibody to HDAC8 (Phospho-Ser39) | 35-1124 |
Polyclonal Antibody to DNA PKcs (Phospho-Thr2609) | 35-1160 |
Polyclonal Antibody to Histone H3.1 (Phospho-Ser10) | 35-1174 |
Polyclonal Antibody to Histone H2A.X (Phospho-Ser139) | 35-1247 |
Polyclonal Antibody to Histone H3 (Phospho-Thr11) | 35-1342 |
Polyclonal Antibody to Histone H3 (Tri-Methyl-Lys27) | 35-1347 |
Polyclonal Antibody to Histone H3 (Di-Methyl-Lys27) | 35-1348 |
Polyclonal Antibody to Histone H3.1 (Ab-10) | 35-1485 |
Polyclonal Antibody to HDAC2 (Ab-394) | 35-1488 |
Polyclonal Antibody to HDAC4 (Ab-632) | 35-1489 |
Polyclonal Antibody to HDAC5 (Ab-498) | 35-1490 |
Polyclonal Antibody to HSP27 (Ab-15) | 35-1491 |
Polyclonal Antibody to DNA PKcs (Ab-2609) | 35-1521 |
Polyclonal Antibody to Histone H2A.X (Ab-139) | 35-1593 |
Polyclonal Antibody to HDAC4/HDAC5/HDAC9 (Ab-246/259/220 | 35-1731 |
Polyclonal Antibody to HDAC3 | 35-1828 |
Polyclonal Antibody to Histone H3 (Ab-27) | 35-1857 |
Anti-Mcm7 Monoclonal Antibody (Clone: DCS-141) | 39-1065 |
Anti-MBD2 Polyclonal Antibody | 39-2005 |
Anti-HDAC3 Polyclonal Antibody | 39-2121 |
Capacities of a cell to receive, analyze, and send messages to its surroundings and within it are known as cell signaling. The cell reacts to various internal and external stimuli through cell signaling pathways. Cells have proteins called receptors that recognize chemical messages or physical stimuli initiating a physiological response that is essential for cell signaling. Transferring information from external stimuli to the cytoplasm, nucleus or other cellular organelles involves many components other than receptors forming cell signaling pathways. Diseases including diabetes, autoimmune illnesses, and cancer are brought on by errors in these cell signaling pathways that are brought on by mutations that can induce constitutive expression, activation, or inhibition of signaling proteins. Precision products for antibody cell signalling have been created using cutting-edge technology created by Abeomics. For your study, we provide a large selection of multi-application verified antibody cell signaling products some of them are Lck, ACE2, Chaperonin, ACP1, MYADM etc.
Infectious diseases are illnesses caused by harmful pathogens like bacteria, viruses, fungi, parasites, and animals and their toxic products through contaminated food, water, or other sources. Infectious diseases continue to harm human health, affecting every aspect of our lives. Infectious diseases are a leading cause of death in most parts of the world. Several vaccines and drugs like antibiotics (for bacterial diseases) have been developed to treat many infectious diseases. The necessity for developing innovative preventative and therapeutic approaches to treat these illnesses has been brought to light by the threat presented by emerging and reemerging infectious diseases. While there are numerous molecular antibody products under development for a range of infectious diseases, the use of antibody preparations to prevent infectious illnesses has a long history.
Abeomics offers a comprehensive selection of antibody solutions for several infectious diseases Like COVID-19, Ebola, MERS, and ZIKA to name a few. These antibodies are created utilizing advanced technologies and enable scientists and researchers to conduct research more efficiently.
Description | Catalog Number |
Coronavirus (COVID-19) Spike Antibody (Clone: ABM19C9) | 10-10007 |
Monoclonal Antibody to Ebola GP II (Clone: ABM4C78) | 10-10021 |
Monoclonal Antibody to Ebola GP I (Clone: ABM47F9) | 10-10022 |
Monoclonal Antibody to MERS-CoV Spike (S) protein (Clone: ABM4A80) | 10-10023 |
Monoclonal Antibody to CHIKV-nsP2 (Clone: ABM3F3.2E10) | 10-10024 |
Monoclonal Antibody to ZIKA E protein (Clone: ABM5A43) | 10-10025 |
Monoclonal Antibody to ZIKA Envelope protein (Clone: ABM54D4) | 10-10026 |
Monoclonal Antibody to ZIKA NS5 (Clone: ABM5G47) | 10-10027 |
Monoclonal Antibody to SARS-CoV-2 Nucleocapsid (Clone: ABM1F11.1E1) | 10-10032 |
Monoclonal Antibody to SARS-CoV-2 Nucleocapsid (Clone: ABM3F2.1C1) | 10-10033 |
Monoclonal Antibody to SARS-CoV-2 Nucleocapsid (Clone: ABM3H4.1F7 | 10-10034 |
Monoclonal Antibody to SARS-CoV-2 nucleocapsid (Clone: ABM4H11.1C12) | 10-10035 |
Anti-SARS CoV2 Spike RBD Antibody (Clone: ABM2A3.1D12) | 10-10036 |
Anti-SARS CoV2 Spike RBD Antibody (Clone: ABM5D1.1E8) | 10-10037 |
Anti-SARS CoV2 Spike RBD Antibody (Clone: ABM5D1.1E8) Biotin Conjugated | 10-10037-B |
Anti-SARS CoV2 Spike RBD Antibody (Clone: ABM5H1.1E4) | 10-10038 |
Anti-SARS CoV2 Spike RBD Antibody (Clone: ABM1H9.1E6) | 10-10039 |
Anti-SARS CoV2 Spike RBD Antibody (Clone: ABM6G1.1A2) | 10-10040 |
SARS CoV2 Spike S1 Antibody (Clone: ABM3D6.1G6) (13-33aa) | 10-10042 |
SARS CoV2 Spike S1 Antibody (Clone: ABM4A10.1D3)(239-257aa) | 10-10043 |
Monoclonal Antibody to SARS-CoV-2 nucleocapsid (Clone: ABM3A11.1B5 | 10-10045 |
Monoclonal Antibody to SARS-CoV-2 nucleocapsid (Clone: ABM5H9.1A2) | 10-10046 |
Monoclonal Antibody to SARS-CoV-2 nucleocapsid (Clone: ABM2D6.2C2) | 10-10047 |
SARS CoV2 Spike S1 Antibody (Clone: ABM1G2.1F7) | 10-10048 |
Anti-Monkeypox B5R Antibody (Clone: ABM2F3.3E5) | 10-10053 |
Anti MonkeyPox L1R Antibody (Clone: ABM1B5.1B11) | 10-10054 |
Anti-Monkeypox A29 Antibody (Clone: ABM5F6.1A6) | 10-10059 |
Anti-Monkeypox A29 Antibody (Clone: ABM6A9.1B3) | 10-10060 |
Recombinant Anti-SARS-CoV-2 Spike RBD antibody (CR3022) | 10-2004 |
Recombinant Anti-SARS-CoV-2 Spike RBD antibody (ABMX-002) | 10-2005 |
Recombinant Anti-SARS-CoV-2 Spike RBD antibody (ABMX-003) | 10-2006 |
Recombinant Anti-SARS-CoV-2 Nucleocapsid antibody (ABMX-004) | 10-2007 |
Coronavirus (COVID-19) Spike Antibody | 11-2001 |
Coronavirus (COVID-19/Sars-Cov-2/2019nCov) Spike biotinylated Antibody | 11-2001-B |
Coronavirus (COVID-19) Spike Protein Antibody | 11-2002 |
Coronavirus (COVID-19) Nucleocapsid Antibody | 11-2003 |
SARS-CoV-2/COVID-19 Nucleocapsid biotinylated Antibody | 11-2003-B |
Polyclonal Antibody to SARS-CoV-2 nucleocapsid Protein | 11-2004 |
Polyclonal Antibody to SARS-CoV-2 nucleocapsid Protein Biotin Conjugated | 11-2004-B |
Anti-ACE2 Polyclonal antibody | 11-2005 |
Polyclonal ACE2 antibody | 11-2006 |
SARS-CoV2 N-Term Nucleocapsid Antibody | 11-2007 |
SARS CoV2 Spike S1 Antibody | 11-2009 |
SARS-CoV-2 Spike S1 Antibody | 11-2021 |
SARS-CoV2 Spike RBD Antibody | 11-2023 |
COVID-19/SARS-CoV-2 Spike S1 Antibody | 11-2024 |
Pan Influenza A Nucleoprotein polyclonal Antibody | 11-2025 |
Pan Influenza A Nucleoprotein polyclonal Antibody | 11-2026 |
Pan Influenza B Nucleoprotein polyclonal Antibody | 11-2027 |
Anti MonkeyPox A29 Polyclonal Antibody | 11-2028 |
Anti Monkey Pox L1R Polyclonal Antibody | 11-2029 |
Anti CRP Polyclonal Antibody | 11-2030 |
Anti SARS-CoV-2 Nucleocapsid rabbit mAb (Clone:75G5a) | 12-4001 |
Anti SARS-CoV-2 Nucleocapsid Rabbit mAb (Clone:75G5a) Biotin Conjugate | 12-4001-B |
Anti SARS-CoV-2 Nucleocapsid rabbit mAb (Clone: 84C4a) | 12-4002 |
Anti SARS-CoV-2 Nucleocapsid Rabbit mAb (Clone:84C4a) Biotin Conjugate | 12-4002-B |
Anti SARS-CoV-2 Nucleocapsid rabbit mAb (Clone: 84D7) | 12-4003 |
Anti SARS-CoV-2 Nucleocapsid Rabbit mAb (Clone:84D7) Biotin Conjugate | 12-4003-B |
Anti SARS-CoV-2 Nucleocapsid rabbit mAb (Clone:85C1) | 12-4004 |
Anti SARS-CoV-2 Nucleocapsid Rabbit mAb (Clone:85C1) Biotin Conjugate | 12-4004-B |
Anti-Chikungunya E2 Protein | 12-8139 |
Anti-SARS-CoV-2 Nucleocapsid antibody(DM22), Rabbit mAb | 12-9012 |
Anti-SARS-CoV-2 Nucleocapsid antibody(DM23), Rabbit mAb | 12-9013 |
Anti-SARS-CoV-2 Spike S2 antibody(DM24), Rabbit mAb | 12-9014 |
Anti-SARS-CoV-2 Spike S2 antibody(DM25), Rabbit mAb | 12-9015 |
Anti-SARS-CoV-2 RBD antibody(DM26), Rabbit mAb | 12-9017 |
Anti-SARS-CoV-2 RBD antibody(DM27), Rabbit mAb | 12-9018 |
Anti-SARS-CoV-2 RBD antibody(DM35), Rabbit mAb | 12-9025 |
Anti-SARS-CoV-2 Nucleocapsid antibody(DM36), Rabbit mAb | 12-9026 |
Anti-SARS-CoV-2 Nucleocapsid antibody(DM37), Rabbit mAb | 12-9027 |
Anti-SARS-CoV-2 Nucleocapsid antibody(DM38), Rabbit mA | 12-9028 |
Anti-SARS-CoV-2 Spike antibody(DM39), Rabbit mAb | 12-9029 |
Anti-SARS-CoV-2 Spike antibody(DM40), Rabbit mAb | 12-9030 |
Anti-SARS-CoV-2 Spike antibody(DM41), Rabbit mAb | 12-9031 |
Anti-SARS-CoV-2 Spike antibody(DM42), Rabbit mAb | 12-9032 |
Anti-SARS-CoV-2 RBD antibody(DM54), Rabbit mAb | 12-9408 |
Anti-SARS-CoV-2 RBD antibody(DM55), Rabbit mAb | 12-9409 |
SARS-CoV-2 Nucleocapsid Antibody (Clone: 1G5) | 29-1006 |
SARS-CoV-2 Nucleocapsid Antibody (Clone: 3C6) | 29-1007 |
Anti-HIV protease Monoclonal Antibody (Clone:1696)-Azide free | 30-1010 |
Anti-Francisella tularensis ssp. tularensis antigen PilT Polyclonal Antibody | 30-1093 |
Anti-Francisella tularensis ssp. tularensis antigen FTT0571 Polyclonal Antibody | 30-1094 |
Anti-Mycobacterium tuberculosis antigen Acr1 Polyclonal Antibody | 30-1098 |
Anti-Mycobacterium tuberculosis antigen Tb10.3 Polyclonal Antibody | 30-1099 |
Anti-Mycobacterium tuberculosis antigen Acr2 Polyclonal Antibody | 30-1100 |
Anti-Mycobacterium tuberculosis antigen Tb7.7 Polyclonal Antibody | 30-1101 |
Anti-Mycobacterium tuberculosis antigen GlcB Polyclonal Antibody | 30-1102 |
Anti-Francisella tularensis ssp. holarctica antigen FTL0187 Polyclonal Antibody | 30-1105 |
Anti-HIV protease Monoclonal Antibody (Clone:1696) | 30-1190 |
Anti-EBV antigen EBNA-1 Monoclonal Antibody (Clone:E1-2.5) | 30-1191 |
Anti-HIV-1 gp24 Monoclonal Antibody (Clone:ND1) | 30-1210 |
Anti-HBV antigen HBsAg Monoclonal Antibody (Clone:HB3) | 30-1211 |
Anti-HBV antigen HBsAg Monoclonal Antibody (Clone:HB5) | 30-1212 |
Anti-HSV1 + HSV2 (gB) Monoclonal Antibody (Clone:T111) | 30-1213 |
Anti-HSV1 (gC) Monoclonal Antibody (Clone:T96) | 30-1214 |
Anti-HSV2 (gG) Monoclonal Antibody (Clone:T303) | 30-1215 |
Anti-Neisseria meningitidis antigen Orf1 / FrpD Polyclonal Antibody | 30-1343 |
Anti-Mycobacterium tuberculosis antigen CFP10 (Rv3874) Polyclonal Antibody | 30-1344 |
Anti-Mycobacterium tuberculosis antigen EsaT-6 (Rv3875) Polyclonal Antibody | 30-1345 |
Anti-Tb10.4 (M. tuberculosis) Antibody | 30-2492 |
Anti-Ag85b (M. tuberculosis) Antibody | 30-2673 |
Mouse Anti-Influenza A, Nucleoprotein | 31-3711 |
Mouse Anti-Influenza A, Nucleoprotein | 31-3712 |
Mouse Anti-Influenza A, Nucleoprotein-HRP Conjugated | 31-3713 |
Mouse Anti-Influenza B, Nucleoprotein | 31-3715 |
Mouse Anti-Influenza B, Nucleoprotein | 31-3716 |
Mouse Anti-Influenza B, Nucleoprotein-HRP Conjugated | 31-3717 |
Mouse monoclonal antibody to SARS-CoV2 (ACE2 binding domain) (Clone:2G1) | 34-1134 |
Mouse monoclonal antibody to SARS-CoV2 (ACE2 binding domain) (Clone:5G8) | 34-1135 |
Rabbit polyclonal antibody to SARS-CoV2 S-protein (ACE2 binding domain) | 34-1136 |
2019-nCoV Nucleocapsid Antibody (Humanized) | 35-1879 |
SARS-CoV-2 (2019-nCoV) Nucleoprotein / NP Antibody, Rabbit MAb | 35-1880 |
Anti-COVID-19 Spike S1 mAb (Clone: 5D9) | 35-1881 |
SARS-CoV-2 (2019-nCoV) Spike Antibody, Rabbit mAb | 35-1882 |
COVID-19 (Sars-Cov-2/ nCov) Spike RBD Antibody (Humanized) | 35-1884 |
COVID-19 (Sars-Cov-2/nCov) Spike RBD Antibody (Humanized-Functional) | 35-1885 |
Monoclonal Antibody to HPV-16 (Human Papilloma Virus 16)(Clone : CAMVIR-1) | 36-11022 |
Monoclonal Antibody to HPV-16 (Human Papilloma Virus 16)(Clone : SPM405) | 36-11023 |
Monoclonal Antibody to HPV-16 (Human Papilloma Virus 16)(Clone : SPM257) | 36-11051 |
Monoclonal Antibody to HPV-16 (Human Papilloma Virus 16)(Clone : HPV16L1/1058) | 36-11062 |
Nuclear Factor-KappaB (NF-KappaB) is a heterodimeric protein made up of various combinations of Rel family transcription factor members. NF-KappaB is activated via the conventional and noncanonical (or alternative) signaling pathways, which, although having different signaling mechanisms, are both crucial for controlling immunological and inflammatory responses. NF-KappaB plays a crucial role in carcinogenesis and is a key regulator of cell fate choices, including the regulation of proliferation and programmed cell death. Toll-like receptors on innate immune system cells that recognize bacterial and viral products also induce NF-KappaB, which triggers the generation of proinflammatory cytokines and the activation of antigen-presenting cells for T-cell costimulation in the adaptive immunological response. Recent research has emphasized the significance of the link between NF-KappaB, inflammation, and cancer as well as the importance of treatments that control NF-KappaB activity.
Abeomics offers a wide variety of polyclonal and monoclonal antibodies, including TRF2, RANK, p50, RANKL, p65, NFKBIL1, and many more which help scientists and researchers conduct research more effectively.
Description | Catalog Number |
Monoclonal Antibody to OPG (Clone: ABM10D2 ) | 10-6001 |
Monoclonal Antibody to TRF2 (Clone: ABM10H3) | 10-6002 |
Monoclonal Antibody to IkB alpha (Clone: ABM10F4) | 10-6003 |
Monoclonal Antibody to RANK (CD265, TNF11aR, ODFR) (Clone: ABM10D5) | 10-6004 |
Monoclonal Antibody to Ikkb (Clone: ABM10E6) | 10-6005 |
Monoclonal Antibody to RANKL (Clone: ABM10A7) | 10-6006 |
Monoclonal Antibody to IKK alpha (Clone: ABM10G9) | 10-6007 |
Monoclonal Antibody to DFF-40 (Clone: ABM1H15) | 10-6008 |
Monoclonal Antibody to p65 (Clone: ABM1A16) | 10-6009 |
Monoclonal Antibody to IkB alpha (Clone: ABM11B7 | 10-6010 |
Monoclonal Antibody to TRAF5 (Clone: ABM12A2) | 10-6013 |
Monoclonal Antibody to RANKL (Clone: ABM12D6) | 10-6014 |
Monoclonal Antibody to Ikke/Ikki/TBK1 (Clone: ABM13C7) | 10-6015 |
Monoclonal Antibody to Ikk Gamma (Clone: ABM15D9) | 10-6017 |
Monoclonal Antibody to kB-Ras1 (Clone: ABM17B5) | 10-6019 |
Monoclonal Antibody to p105/p50 (Clone: ABM20H5) | 10-6021 |
Anti-Ikkb Monoclonal Antibody (Clone: ABM42D1) | 10-6023 |
Polyclonal Antibody to TAB3 | 11-6001 |
Polyclonal Antibody to p65 | 11-6002 |
Polyclonal Antibody to CUEDC2 | 11-6003 |
Polyclonal Antibody to NFKBIL1 | 11-6005 |
Polyclonal Antibody to HOIP/RNF31 | 11-6006 |
Polyclonal Antibody to HOIL-1L/RBCK1 | 11-6007 |
Polyclonal Antibody to ERS25 | 11-6010 |
Polyclonal Antibody to p50 | 11-6011 |
Polyclonal antibody to NIK | 11-6012 |
Phospho-NFkB p65 (Ser536) (Clone: C8) rabbit mAb | 12-4139 |
Phospho-NFKB p65 (Ser536) (Clone: B7) rabbit mAb | 12-4307 |
Phospho-NFKB p65 (Ser536) (Clone: B7) rabbit mAb PE conjugate | 12-4308 |
Phospho-NFKB p65 (Ser536) (Clone: B7) rabbit mAb FITC Conjugate | 12-4309 |
Phospho-NFKB p65 (Ser536) (Clone: B7) rabbit mAb APC Conjugate | 12-4310 |
Phospho-NFkB p65 (Ser529) (Clone: A2) rabbit mAb | 12-4315 |
Phospho-NFkB p65 (Ser529) (Clone: H3) rabbit mAb | 12-4316 |
Phospho-NFkB p65 (Ser529) (Clone: H3) rabbit mAb PE conjugate | 12-4317 |
Phospho-NFkB p65 (Ser529) (Clone: H3) rabbit mAb FITC conjugate | 12-4318 |
Phospho-NFkB p65 (Ser529) (Clone: H3) rabbit mAb APC conjugate | 12-4319 |
Phospho-NFKB p65 (Ser468) (Clone: B9) rabbit mAb | 12-4344 |
Anti-GRAP2/GADS Monoclonal Antibody (Clone:UW40) | 30-1448 |
Anti-GRAP2 APC (Clone : UW40) | 30-2528 |
Anti-GRAP2 PE (Clone : UW40) | 30-2529 |
Polyclonal Antibody to NFkB-p65 (Phospho-Thr254) | 35-1009 |
Polyclonal Antibody to NFkB-p65(Phospho-Ser276) | 35-1010 |
Polyclonal Antibody to NFkB-p65(Phospho-Thr435) | 35-1011 |
Polyclonal Antibody to NFkB-p65(Phospho-Ser468) | 35-1012 |
Polyclonal Antibody to NFkB-p65 (Phospho-Ser536) | 35-1013 |
Polyclonal Antibody to NFkB-p100/p52(Phospho-Ser866) | 35-1014 |
Polyclonal Antibody to NFkB-p100/p52(Phospho-Ser870) | 35-1015 |
Polyclonal Antibody to NFkB-p105/p50(Phospho-Ser337) | 35-1016 |
Polyclonal Antibody to NFkB-p105/p50(Phospho-Ser893) | 35-1017 |
Polyclonal Antibody to NFkB-p105/p50(Phospho-Ser907) | 35-1018 |
Polyclonal Antibody to Rel (Phospho-Ser503) | 35-1019 |
Polyclonal Antibody to IKK Alpha (Phospho-Thr23) | 35-1125 |
Polyclonal Antibody to IkB- Alpha (Phospho-Tyr42) Antibody | 35-1155 |
Polyclonal Antibody to NFkB-p65 (Phospho-Thr505) | 35-1159 |
Polyclonal Antibody to NFkB-p105/p50 (Phospho-Ser932) | 35-1232 |
Polyclonal Antibody to NFkB-p65((phospho-Ser311) | 35-1240 |
Polyclonal Antibody to IkB-beta (Phospho-Ser23) | 35-1274 |
Polyclonal Antibody to IKK-beta(Phospho-Tyr199) | 35-1275 |
Polyclonal Antibody to NFkB-p105/p50 (Phospho-Ser927) | 35-1281 |
Polyclonal Antibody to NFkB-p65 (Ab-254) | 35-1367 |
Polyclonal Antibody to NFkB-p65 (Ab-276) | 35-1368 |
Polyclonal Antibody to NFkB -p65 (Ab-435) | 35-1369 |
Polyclonal Antibody to NFkB-p65 (Ab-468) | 35-1370 |
Polyclonal Antibody to NFkB-p65 (Ab-536) | 35-1371 |
Polyclonal Antibody to NFkB-p100/p52 (Ab-866) | 35-1372 |
Polyclonal Antibody to NFkB-p100/p52 (Ab-870) | 35-1373 |
Polyclonal Antibody to NFkB-p105/p50 (Ab-337) | 35-1374 |
Polyclonal Antibody to NFkB-p105/p50 (Ab-893) | 35-1375 |
Polyclonal Antibody to NFkB-p105/p50 (Ab-907) | 35-1376 |
Polyclonal Antibody to Rel (Ab-503) | 35-1377 |
Polyclonal Antibody to IkB- Alpha (Ab-32/36) | 35-1471 |
Polyclonal Antibody to IKK Alpha (Ab-23) | 35-1472 |
Polyclonal Antibody to IkB- Alpha (Ab-42) | 35-1518 |
Polyclonal Antibody to NFkB-p65 (Ab-311) | 35-1585 |
Polyclonal Antibody to IkB-epsilon (Ab-22) | 35-1624 |
Polyclonal Antibody to NFkB-p100/p52 (Ab-872) | 35-1625 |
Polyclonal Antibody to IKK-beta (Ab-199) | 35-1630 |
Polyclonal Antibody to NFkB-p105/p50 (Ab-927) | 35-1634 |
Cancer is a group of disorders characterized by changes in the status and expression of several genes that provide somatic or germinal cells an advantage in survival and unrestricted capacity for cell division. Biochemical signs indicating the existence of cancer are known as cancer markers. Tumor indicators might be proteins, conjugated proteins, peptides, or carbohydrates depending on their chemical makeup. The majority of gene sequencing for medical diagnosis falls under the biomarker category. In clinical practice, it refers to a chemical that may be found in plasma and bodily fluids. Oncologists utilize a variety of cancer markers to assist identify the presence of cancer, each of which is suggestive of a unique disease phase. The body either develops these indicators in reaction to malignant cell invasion or as a result of cancer cells (tumor-associated). Cancer markers are not the primary modalities for cancer diagnosis rather they can be used as laboratory tests to support the diagnosis.
Abeomics has created a variety of cancer indicators, some of which PD-1, CD56, PD-L1, MMP2, PD-L2, and MUC4 aid scientists and researchers in doing studies more successfully.
The quality of the samples and equal loading are assessed using loading control antibodies. Proteins used as loading controls are generally chosen for their abundance and widespread expression in all cell types and tissues. Loading controls serve several functions in a Western blot analysis. First, loading controls offer a quantitative research approach that enables researchers to estimate the protein concentrations in each lane even when they have not been loaded uniformly. To account for the variations in loading, the density of the loading control band is implemented. Loading controls improve the quality of the data obtained by helping to correct mistakes and guarantee the correctness of the data utilized to draw important conclusions. Beta-actin and GADPH are two proteins with widespread high expression that are frequently utilized as loading controls.
Abeomics has created a variety of loading controls, including GAPDH, Beta actin, Beta Tubulin, and Anti-beta-tubulin, among others, to aid scientists and researchers in conducting their study effectively.
Description | Catalog Number |
Monoclonal Antibody to GAPDH (Clone: ABM22C5) | 10-10011 |
Polyclonal Antibody to Beta Tubulin | 11-13002 |
Polyclonal Antibody to Beta actin | 11-13012 |
Polyclonal Antibody to GAPDH | 11-13024 |
Anti-alpha-tubulin Monoclonal Antibody (Clone:TU-01) | 30-1152 |
Anti-beta-tubulin Monoclonal Antibody (Clone:TU-06) | 30-1153 |
Anti-alpha-tubulin Monoclonal Antibody (Clone:TU-16) | 30-1175 |
Anti-GAPDHS Monoclonal Antibody (Clone:Hs-8) | 30-1189 |
Anti-beta-tubulin Monoclonal Antibody (Clone:TU-12) | 30-1293 |
Anti-beta-tubulin / TUBB Monoclonal Antibody (Clone:TU-13) | 30-1306 |
Anti-alpha, beta-tubulin dimer Monoclonal Antibody (Clone:TU-08) | 30-1307 |
Anti-alpha, beta-tubulin dimer Monoclonal Antibody (Clone:TU-10) | 30-1308 |
Anti-alpha-tubulin Monoclonal Antibody (Clone:TU-02) | 30-1309 |
Anti-gamma-tubulin 1 Monoclonal Antibody (Clone:TU-30) | 30-1323 |
Anti-gamma-tubulin Monoclonal Antibody (Clone:TU-32) | 30-1380 |
Anti-Actin Monoclonal Antibody (Clone:HHF35) | 30-1421 |
Biotin Conjugated, Anti-alpha-tubulin Monoclonal Antibody (Clone:TU-01) | 30-1857 |
FITC Conjugated, Anti-alpha-tubulin Monoclonal Antibody (Clone:TU-01) | 30-1964 |
Anti-GAPDHS FITC (Clone : Hs-8) | 30-2531 |
Monoclonal Antibody to Beta Tubulin(Clone: 1B12) | 34-1116 |
Monoclonal Antibody to Beta Tubulin(Clone: 4E4) | 34-1117 |
Polyclonal Antibody to beta-actin | 35-1654 |
Polyclonal Antibody to GAPDH | 35-1782 |
Polyclonal Antibody to Tubulin beta-III | 35-1787 |
Anti-alpha-Tubulin Monoclonal Antibody (Clone: DM1A) | 39-1057 |
Anti-beta-Tubulin Monoclonal Antibody (Clone: TUB 2.1) | 39-1060 |
Stem cells are unspecialized cells with the ability to self-renew and develop into specific cell types, such as neurons, liver cells, or muscle cells. The differentiated cells that make up the tissues and organs of animals and plants are continuously produced from stem cells. Adult stem cells and embryonic stem cells are the two basic types of stem cells. Embryonic stem cells: Unwanted embryos are the source of the embryonic stem cells used in research today. These are the end result of in vitro fertilization. Adult stem cells come in two different varieties. One type originates from tissues that are completely grown, like the bone marrow, skin, and brain. Incremented pluripotent stem cells are the second kind. These are adult stem cells that have undergone laboratory modification to resemble embryonic stem cells more closely. Stem cells are significant in medical research and drug development because they have the potential to treat a number of ailments.
Abeomics offer a broad collection of stem cell antibodies used in many applications such as flow cytometry, cell screening, ELISAs, and western blotting. Some important stem cell antibodies include Polyclonal Antibody to Nanog, Polyclonal Antibody to ERAS, Polyclonal Antibody to Otx2, Polyclonal Antibody to MRF2, Monoclonal Antibody to Lif and Monoclonal Antibody to Wnt5A that are useful for scientists and researchers to conduct their research in an efficient manner.
Description | Catalog Number |
Monoclonal Antibody to Lif (Clone: ABM2C57) | 10-10012 |
Monoclonal Antibody to Wnt5A (Clone: ABM2A39) | 10-8009 |
Polyclonal Antibody to Nanog | 11-12001 |
Polyclonal Antibody to DDX4 | 11-12003 |
Polyclonal Antibody to KLF4 | 11-12004 |
Polyclonal Antibody to GNPDA1 | 11-12005 |
Polyclonal Antibody to THEM2 | 11-12007 |
Polyclonal Antibody to MEIS1 | 11-12008 |
Polyclonal antibody to Cbx5 | 11-12009 |
Polyclonal Antibody to SOX17 | 11-12010 |
Polyclonal Antibody to HMGB3 | 11-12011 |
Polyclonal Antibody to Cbx5 | 11-12012 |
Polyclonal Antibody to SC1 | 11-12014 |
Polyclonal Antibody to POU3F2 | 11-12016 |
Polyclonal Antibody to MRF2 | 11-12017 |
Polyclonal Antibody to SPZ1/TSP1 | 11-12019 |
Polyclonal Antibody to HOXA9 | 11-12020 |
Polyclonal Antibody to HOXB4 | 11-12021 |
Polyclonal Antibody to NKX2-5 | 11-12023 |
Polyclonal Antibody to DLX3/distal-less homeobox 3 | 11-12024 |
Polyclonal Antibody to Otx | 11-12025 |
Polyclonal Antibody to HOXA9 | 11-12026 |
Polyclonal Antibody to OCT1 | 11-12027 |
Polyclonal Antibody to GLI1 | 11-12029 |
Polyclonal Antibody to Stellar | 11-12035 |
Polyclonal Antibody to Fibroblast growth factor 20 | 11-12038 |
Polyclonal Antibody to KLF | 11-12039 |
Polyclonal Antibody to DPPA4 | 11-12042 |
Polyclonal Antibody to HOX7/MSX-1 | 11-12044 |
Polyclonal Antibody to SOX9 | 11-12045 |
Polyclonal Antibody to NRF2 | 11-12046 |
Polyclonal Antibody to HoxD8 | 11-12047 |
Polyclonal Antibody to ERAS | 11-12048 |
Polyclonal Antibody to HEY1 | 11-12052 |
Polyclonal Antibody to FOXC1 | 11-12053 |
Polyclonal Antibody to Glial Fibrillary Acidic Protein,GFAP | 34-1042 |
Polyclonal Antibody to Glial Fibrillary Acidic Protein, GFAP | 34-1046 |
Polyclonal Antibody to Nanog | 35-1677 |
Polyclonal Antibody to OCT4 | 35-1678 |
Polyclonal Antibody to SOX2 | 35-1679 |
Polyclonal Antibody to Lin28 | 35-1680 |
Polyclonal Antibody to LIN28B | 35-1795 |
Anti-Wnt7a Polyclonal Antibody | 39-2011 |
A multicellular creature can go through processes known as development and differentiation whereby it begins with a single cell, the zygote, and develops into various tissues and organs made up of various cell types. Cellular differentiation, the establishment of tissues and organs, the division of cells, and the determination of body axes are all aspects of development. The recent development of bispecific antibodies presents exciting new possibilities for the creation of novel protein therapies. Bispecific antibodies can therefore be created to have unique properties that are missing from combinations of the two parental antibodies. The majority of bispecific antibodies are made to direct immune system’s cytotoxic effector cells toward diseased cells.
Abeomics offers a wide selection of high-quality antibodies for our customers, including polyclonal antibodies to Wnt5a, FMNL3, SIP1 receptor/Edg-1, APG16L, and DLL1. This ensures that our research customers have access to the precise materials they require for their investigations. We also provide a wide range of additional advantages to support our clients’ affordability, convenience, and dependability.
Description | Catalog Number |
Polyclonal Antibody to Wnt5a | 11-10006 |
Polyclonal Antibody to CD133/Prominin-1 | 11-10007 |
Polyclonal Antibody to Formin-like protein 2 | 11-10008 |
Polyclonal Antibody to FMNL3 | 11-10010 |
Polyclonal Antibody to Dapper homolog 1 | 11-10012 |
Polyclonal Antibody to Vang like-1 | 11-10013 |
Polyclonal Antibody to SIP1 receptor/Edg-1 | 11-10014 |
Polyclonal Antibody to S1P3 receptor, Edg-3 | 11-10017 |
Polyclonal Antibody to UBE1L2/MOP-4 | 11-10018 |
Polyclonal Antibody to APG16L | 11-10020 |
Polyclonal Antibody to DAAM1 | 11-10023 |
Polyclonal Antibody to Dishevelled-3 | 11-10024 |
Polyclonal Antibody to Brachyury | 11-10026 |
Polyclonal Antibody to PER1 | 11-10027 |
Polyclonal Antibody to CDX3 | 11-10030 |
Polyclonal Antibody to DLL4 | 11-10033 |
Polyclonal Antibody to DLL1 | 11-10034 |
Polyclonal Antibody to APH1A | 11-10036 |
Polyclonal Antibody to FABP7 | 11-10037 |
Polyclonal Antibody to Delta like 3 | 11-10038 |
Polyclonal Antibody to Twistnb | 11-10040 |
Polyclonal Antibody to CRABP2 | 11-10041 |
Polyclonal Antibody to FAM3C | 11-10043 |
Polyclonal Antibody to Nogo-B | 11-10044 |
Polyclonal Antibody to ALAS1 | 11-10045 |
Polyclonal Antibody to FNBP1 | 11-10046 |
Polyclonal Antibody to c-Maf | 11-10047 |
Phospho-MCM2 (Ser139) (Clone: B12) rabbit mAb | 12-4329 |
Phospho-MCM2 (Ser139) (Clone: B12) rabbit mAb PE conjugate | 12-4330 |
Phospho-MCM2 (Ser139) (Clone: B12) rabbit mAb FITC conjugate | 12-4331 |
Phospho-MCM2 (Ser139) (Clone: B12) rabbit mAb APC conjugate | 12-4332 |
Anti-DLL4 PE (Clone : MHD4-46) | 30-2532 |
Mouse Anti-Human GFAP | 31-3756 |
Mouse Anti-Human GFAP-HRP Conjugated | 31-3757 |
Mouse Anti-Human GFAP-Biotin Conjugated | 31-3758 |
Mouse Anti-Human GFAP-CY3 | 31-3759 |
Polyclonal Antibody to Coronin 1a | 34-1026 |
Monoclonal Antibody to DCX Doublecortin (Clone: 3E1) | 34-1028 |
Monoclonal Antibody to a-internexin/NF66 (Clone: 1D2) | 34-1052 |
Monoclonal Antibody to a-internexin/NF66 (Clone: 2E3) | 34-1053 |
Polyclonal Antibody to a-internexin/NF66 | 34-1054 |
Polyclonal Antibody to a-internexin/NF66 | 34-1055 |
Anti-Sonic Hedgehog Polyclonal Antibody | 39-2057 |
Description | Catalog Number |
Mouse IgG1 Isotype Control (Clone: MOPC31C) | 10-101 |
Mouse IgG1 Isotype Control (Clone: MOPC31C)- FITC | 10-101-F |
Mouse IgG2a Isotype Control (Clone: 231) | 10-102 |
Mouse IgG2a Isotype Control (Clone: 231)- FITC | 10-102-F |
Mouse IgG2a Isotype Control (Clone: 231)- PE | 10-102-P |
Mouse IgG2b Isotype Control (Clone: MOPC II) | 10-103 |
Mouse IgG2b Isotype Control (Clone: MOPC II)- FITC | 10-103-F |
Rat IgG1 Isotype Control (Clone: HRPN) | 10-105 |
Rat IgG1 Isotype Control (Clone: HRPN)- FITC | 10-105-F |
Rat IgG2a Isotype Control (Clone: 2A3) | 10-106 |
Rat IgG2a Isotype Control (Clone: 2A3)- FITC | 10-106-F |
Rat IgG2b Isotype Control (Clone: LTF-2) | 10-107 |
Rat IgG2b Isotype Control (Clone: LTF-2)- FITC | 10-107-F |
Rabbit IgG Isotype Control | 11-201 |
Rabbit IgG Isotype control-APC Conjugated | 11-201-AC |
Rabbit IgG Isotype Control- FITC Conjugated | 11-201-F |
Rabbit IgG Isotype control- PE Conjugated | 11-201-PE |
Isotype Control (Clone: G9) rabbit mAb | 12-4086 |
Isotype Control (Clone: G9) rabbit mAb PE Conjugate | 12-4183 |
Isotype Control (Clone: G9) rabbit mAb FITC Conjugate | 12-4184 |
Isotype Control (Clone: G9) rabbit mAb APC Conjugate | 12-4185 |
Azide free Mouse IgG2a Isotype Control Monoclonal Antibody (Clone:PPV-04) | 30-1020 |
Mouse IgG1 Isotype Control Monoclonal Antibody (Clone:PPV-06) | 30-1317 |
Mouse IgG2a Isotype Control Monoclonal Antibody (Clone:PPV-04) | 30-1318 |
Mouse IgG3 Isotype Control Monoclonal Antibody (Clone:PPV-07) | 30-1319 |
Mouse IgG2b Isotype Control Monoclonal Antibody (Clone:MPC-11) | 30-1494 |
Mouse IgG2a Isotype Control Monoclonal Antibody (Clone:MOPC-173) | 30-1522 |
Mouse IgG2b Isotype Control Monoclonal Antibody (Clone:PLRV219) | 30-1578 |
Mouse IgM Isotype Control Monoclonal Antibody (Clone:PFR-03) | 30-1579 |
Low Endotoxin Mouse IgG1 Isotype Control Monoclonal Antibody (Clone:MOPC-21) | 30-1639 |
Low Endotoxin Mouse IgG2a Isotype Control Monoclonal Antibody (Clone:MOPC-173) | 30-1651 |
APC Conjugated Mouse IgG1 Isotype Control Monoclonal Antibody (Clone:MOPC-21) | 30-1771 |
APC Conjugated Mouse IgG2b Isotype Control Monoclonal Antibody (Clone:MPC-11) | 30-1805 |
APC Conjugated Mouse IgG2a Isotype Control Monoclonal Antibody (Clone:MOPC-173) | 30-1811 |
Biotin Conjugated Mouse IgG1 Isotype Control Monoclonal Antibody (Clone:MOPC-21) | 30-1901 |
Biotin Conjugated Mouse IgG2b Isotype Control Monoclonal Antibody (Clone:MPC-11) | 30-1911 |
Biotin Conjugated Mouse IgG2a Isotype Control Monoclonal Antibody (Clone:MOPC-173) | 30-1915 |
FITC Conjugated Mouse IgG2b Isotype Control Monoclonal Antibody (Clone:MPC-11) | 30-2097 |
FITC Conjugated Mouse IgG2a Isotype Control Monoclonal Antibody (Clone:MOPC-173) | 30-2102 |
FITC Conjugated Mouse IgM Isotype Control Monoclonal Antibody (Clone:PFR-03) | 30-2113. |
PE Conjugated Mouse IgG1 Isotype Control Monoclonal Antibody (Clone:MOPC-21) | 30-2292 |
PE Conjugated Mouse IgG2b Isotype Control Monoclonal Antibody (Clone:MPC-11) | 30-2338 |
PE Conjugated Mouse IgG2a Isotype Control Monoclonal Antibody (Clone:MOPC-173) | 30-2356 |
PerCP Conjugated Mouse IgG1 Isotype Control Monoclonal Antibody (Clone:MOPC-21) | 30-2447 |
PerCP Conjugated Mouse IgG2b Isotype Control Monoclonal Antibody (Clone:MPC-11) | 30-2455 |
PerCP Conjugated Mouse IgG2a Isotype Control Monoclonal Antibody (Clone:MOPC-173) | 30-2456 |
PE/DyLight Conjugated Mouse IgG1 Isotype Control Monoclonal Antibody (Clone:MOPC-21) | 30-2474 |
Rat IgG2a Isotype Control Antibody (Clone : S193) | 30-2674 |
Rat IgG2b Isotype Control Antibody (Clone : S193) | 30-2675 |
Rat IgG2a Isotype Control LOW ENDOTOXIN Antibody (Clone : S193) | 30-2676 |
Rat IgG2b Isotype Control LOW ENDOTOXIN Antibody (Clone : S193) | 30-2677 |
Rat IgG2a Isotype Control APC Antibody (Clone : S193) | 30-2678 |
Rat IgG2b Isotype Control FITC Antibody (Clone : S193) | 30-2679 |
Rat IgG2a Isotype Control PE Antibody (Clone : S193) | 30-2680 |
Mouse IgG3 Isotype Control DyLight® 488 (Clone : PPV-07) | 30-2681 |
Mouse IgG1 Isotype Control DyLight® 488 (Clone : MOPC-21) | 30-2682 |
Mouse IgG2b Isotype Control DyLight® 488 (Clone : MPC-11) | 30-2683 |
Mouse IgG2a Isotype Control DyLight® 488 (Clone : MOPC-173) | 30-2684 |
Mouse IgG3 Isotype Control DyLight® 650 (Clone : PPV-07) | 30-2686 |
Mouse IgG1 Isotype Control DyLight® 650 (Clone : MOPC-21) | 30-2687 |
Mouse IgG2b Isotype Control DyLight® 650 (Clone : MPC-11) | 30-2688 |
Mouse IgG2a Isotype Control DyLight® 650 (Clone : MOPC-173) | 30-2689 |
Mouse IgG control (Whole Molecule), Purified | 45-1029 |
Rabbit IgG Control (Whole Molecule), Purified | 45-1030 |
Secondary antibodies are essential tools in immunological research. They play a crucial role in detecting and amplifying signals generated by primary antibodies, which directly bind to target antigens. Secondary antibodies are raised against the species-specific immunoglobulins of primary antibodies, enabling researchers to perform multiple labeling and signal enhancement techniques in various experimental applications, such as Western blotting, immunohistochemistry, and flow cytometry. These versatile reagents are labeled with enzymes, fluorescent dyes, or other markers, making them indispensable for the visualization and quantification of specific antigens in complex biological samples.
Abeomics provides a diverse selection of secondary antibodies, catering to your research needs. Our range includes secondary antibodies derived from various host species.
Secondary antibodies are essential tools in immunological research. They play a crucial role in detecting and amplifying signals generated by primary antibodies, which directly bind to target antigens. Secondary antibodies are raised against the species-specific immunoglobulins of primary antibodies, enabling researchers to perform multiple labeling and signal enhancement techniques in various experimental applications, such as Western blotting, immunohistochemistry, and flow cytometry. These versatile reagents are labeled with enzymes, fluorescent dyes, or other markers, making them indispensable for the visualization and quantification of specific antigens in complex biological samples.
Abeomics provides a diverse selection of secondary antibodies, catering to your research needs. Our range includes secondary antibodies derived from various host species.
Description | Catalog Number |
Monoclonal Antibody to c-MYC (Clone:9 E 10) | 10-10013 |
Anti-beta-Galactosidase Monoclonal Antibody (Clone:BG-02) | 30-1162 |
Anti-GFP / Green Fluorescent Protein Polyclonal Antibody | 30-1330 |
Anti-GST / Glutathione-S-Transferase, GST tag Monoclonal Antibody (Clone:S-tag-05) | 30-1331 |
Anti-Nitrotyrosine Monoclonal Antibody (Clone:EM-30) | 30-1495 |
Anti-c-Myc / Cellular myelocytomatosis oncogene Monoclonal Antibody (Clone:9E10)-Biotin Conjugated | 30-1885 |
Anti-c-Myc / Cellular myelocytomatosis oncogene Monoclonal Antibody (Clone:9E10)-FITC Conjugated | 30-2007 |
Anti-c-Myc / Cellular myelocytomatosis oncogene Monoclonal Antibody (Clone:9E10) | 30-2409 |
Polyclonal Antibody to Myc (Ab-58) | 35-1391 |
Polyclonal Antibody to Myc (Ab-358) | 35-1392 |
Rabbit Polyclonal Antibody to DYKDDDDK-tag | 45-1004 |
Rabbit Polyclonal Antibody to c-Myc-tag | 45-1005 |
Rabbit Polyclonal Antibody to His-tag | 45-1006 |
Mouse Monoclonal Antibody to Trx-tag (Clone : 4C12H10) | 45-1007 |
Mouse Monoclonal Antibody to cGFP-tag (Clone : 5E5G11) | 45-1008 |
Rabbit Polyclonal Antibody to CBP-tag | 45-1015 |
Rabbit Polyclonal Antibody to Avi-tag | 45-1018 |
Rabbit Polyclonal Antibody to S1-tag | 45-1021 |
Rabbit Polyclonal Antibody to RFP-tag | 45-1022 |
HRP conjugated Rabbit Polyclonal Antibody to E-tag | 45-1025 |
Rabbit Polyclonal Antibody to Ty1-tag | 45-1027 |
Rabbit Polyclonal Antibody to GFP | 45-1042 |
Mouse Monoclonal Antibody to SUMO-tag (Clone : 4G11E9) | 45-1059 |
Mouse Monoclonal Antibody to CBP Tag (Clone : 1D11E5) | 45-1069 |
Rabbit Monoclonal Antibody to His Tag (C-term) (Clone : 25B6E11) | 45-1089 |
Rabbit Monoclonal Antibody to DYKDDDDK Tag (Clone : 114F12C8) | 45-1095 |
HRP conjugated Rabbit Monoclonal Antibody to DYKDDDDK Tag (Clone : 114F12C8) | 45-1096 |
Biotinylated Rabbit Monoclonal Antibody to DYKDDDDK Tag (Clone : 114F12C8) | 45-1097 |
HRP conjugated Mouse Monoclonal Antibody to His-tag (Clone : 6G2A9) | 45-1121 |
Description | Catalog Number |
Monoclonal Antibody to OCIL (Clone: ABM17H3) | 10-10002 |
Anti-Presenilin 2 Monoclonal Antibody (Clone: ABM1B86) | 10-10004 |
Monoclonal Antibody to Androgen receptor (Clone: ABM20C2) | 10-10008 |
Monoclonal antibody to GPR44 (Clone: ABM2H76) | 10-10014 |
Monoclonal antibody to GPR44 (Clone: ABM2C77) | 10-10015 |
Monoclonal Antibody to BEX (Clone: ABM29C7) | 10-10016 |
Anti- HA-Tag Monoclonal Antibody (Clone: 12CA5) | 10-10019 |
Monoclonal Antibody to ZIKA E protein (Clone: ABM5A43) | 10-10025 |
Monoclonal Antibody to ZIKA Envelope protein (Clone: ABM54D4) | 10-10026 |
Monoclonal Antibody to ZIKA NS5 (Clone: ABM5G47) | 10-10027 |
Protein A Monoclonal Antibody (Clone: ABM2A4.1E3) | 10-10049 |
Protein A Monoclonal Antibody (Clone: ABM4B3.1G3) | 10-10050 |
Protein A Monoclonal Antibody (Clone: ABM1A8.1C1) | 10-10051 |
Anti Monkeypox L1R Antibody (Clone: ABM4F12.1B7) | 10-10055 |
Anti Monkeypox L1R Antibody (Clone: ABM4F8.1B9) | 10-10056 |
Anti MonkeyPox L1R Antibody (Clone: ABM4G5.1A3) | 10-10057 |
Anti Monkeypox L1R Antibody (Clone: ABM5H1.1D4) | 10-10058 |
Mouse Monoclonal Antibody to Insulin Receptor (Clone: IR-1) | 10-7605 |
Anti Trastuzumab antibody | 11-13026 |
Anti-MFG Monoclonal Antibody (Clone:MFG-06) | 30-1048 |
Anti-Chorionic gonadotropin (beta-hCG) Monoclonal Antibody (Clone:HCG-61) | 30-1054 |
Anti-Thyrotropin (hTSH) Monoclonal Antibody (Clone:TSH-51) | 30-1055 |
Anti-Thyrotropin (hTSH) Monoclonal Antibody (Clone:TSH-116) | 30-1056 |
Anti-Growth hormone (hGH) Monoclonal Antibody (Clone:GH-45) | 30-1057 |
Anti-Insulin Monoclonal Antibody (Clone:IN-05) | 30-1149 |
Anti-C-peptide of Proinsulin Monoclonal Antibody (Clone:C-PEP-01) | 30-1150 |
Anti-beta Endorphin Monoclonal Antibody (Clone:B31.15) | 30-1151 |
Anti-Acrosin (Porcine) Monoclonal Antibody (Clone:ACR-2) | 30-1161 |
Anti-Horseradish peroxidase (HRP) Monoclonal Antibody (Clone:HP-03) | 30-1163 |
Anti-Intra-Acrosomal Protein (Canine) Monoclonal Antibody (Clone:Ds-2) | 30-1174 |
Anti-Sialyl Lewis a / CA-19.9 Monoclonal Antibody (Clone:121SLE) | 30-1176 |
Anti-VCP Monoclonal Antibody (Clone:Hs-14) | 30-1188 |
Anti-Benzo[a]pyrene Monoclonal Antibody (Clone:BAP-13) | 30-1217 |
Anti-Tenascin Monoclonal Antibody (Clone:T2H5) | 30-1246 |
Anti-Blood Group Lewis a Monoclonal Antibody (Clone:7LE) | 30-1260 |
Anti-Blood Group Lewis b Monoclonal Antibody (Clone:2-25LE) | 30-1261 |
Anti-Placental alkaline phosphatase Monoclonal Antibody (Clone:H7E8) | 30-1266 |
Anti-Thyroglobulin Monoclonal Antibody (Clone:2H11) | 30-1324 |
Anti-5-bromodeoxyuridine (BrdU) Monoclonal Antibody (Clone:Bu20a) | 30-1486 |
Anti-PCLO Monoclonal Antibody (Clone:PCLO-01) | 30-1500 |
Anti-OPAL1 Monoclonal Antibody (Clone:OPAL1-01) | 30-1501 |
Anti-LARGE1 Monoclonal Antibody (Clone:LARGE-02) | 30-1504 |
Anti-PDE8a Monoclonal Antibody (Clone:EM-52) | 30-1511 |
Anti-AGPS Monoclonal Antibody (Clone:AGPS-03) | 30-1533 |
Low Endotoxin Anti-Insulin Monoclonal Antibody (Clone:IN-05) | 30-1602 |
Biotin Conjugated, Anti-C-peptide of Proinsulin Monoclonal Antibody (Clone:C-PEP-01) | 30-1856 |
FITC Conjugated Anti-VCP Monoclonal Antibody (Clone:Hs-14) | 30-1977 |
PE Conjugated, Anti-5-bromodeoxyuridine (BrdU) Monoclonal Antibody (Clone:Bu20a) | 30-2333 |
PE Conjugated Anti-PCLO Monoclonal Antibody (Clone:PCLO-01) | 30-2342 |
PE Conjugated Anti-OPAL1 Monoclonal Antibody (Clone:OPAL1-01) | 30-2343 |
PE Conjugated Anti-LARGE1 Monoclonal Antibody (Clone:LARGE-02) | 30-2346 |
Anti-Blood Group A Monoclonal Antibody (Clone:HE-195) | 30-2413 |
Anti-Blood Group B Monoclonal Antibody (Clone:HEB-29) | 30-2414 |
Anti-Blood Group A1B Monoclonal Antibody (Clone:HE-24) | 30-2415 |
Anti-Blood Group A Monoclonal Antibody (Clone:HE-193) | 30-2416 |
Anti-Blood Group ABH Monoclonal Antibody (Clone:HE-10) | 30-2417 |
PerCP Conjugated, Anti-CD15 / Lewis x Blood Group antigen Monoclonal Antibody (Clone:MEM-158) | 30-2423 |
Anti-Dendra2 Antibody | 30-2533 |
Anti-Blood Group A Antibody (Clone : HE-193) | 30-2671 |
Anti-TIAR Purified | 30-2710 |
Anti-TAp63 Purified | 30-2718 |
Anti-PPM1D Purified | 30-2720 |
Anti-Hu NKp80 Purified | 30-2726 |
Anti-mPlum purified | 30-2727 |
Anti-mCherry purified | 30-2728 |
Anti-Hu deltaNp73 Purified | 30-2740 |
Anti-Biotin Mab(1D4-C5) | 30-2889 |
Monoclonal Antibody to Aldolase C: C terminal (Clone: 1A1) | 34-1007 |
Monoclonal Antibody to Aldolase C: N terminal (Clone: 4A9) | 34-1008 |
Monoclonal Antibody to Amyloid- Beta (Clone: AB9) | 34-1009 |
Polyclonal Antibody to Cherry Dsred | 34-1023 |
Polyclonal Antibody to Cherry Dsred | 34-1024 |
Monoclonal Antibody to Cherry Dsred (Clone: 1C51) | 34-1025 |
Polyclonal Antibody to GAP43 | 34-1038 |
Monoclonal Antibody to GAP43 (Clone: 5E8) | 34-1040 |
Polyclonal Antibody to GAP43 | 34-1041 |
Monoclonal Antibody to Glyceraldehyde 3-Phosphate Dehydrogenase (Clone: 1D4) | 34-1047 |
Polyclonal Antibody to Glyceraldehyde 3-Phosphate Dehydrogenase | 34-1048 |
Monoclonal Antibody to Nsp1p (Clone: 32D6) | 34-1094 |
Anti-Collagen, Type III Monoclonal Antibody (Clone: FH-7A) | 39-1026 |
Anti-Collagen, Type IV Monoclonal Antibody (Clone: COL-94) | 39-1027 |
Anti-Aquaporin 1 Polyclonal Antibody | 39-2022 |
Mouse Monoclonal Antibody to Pembrolizumab (Clone : 1D6E10) | 45-1083 |
Biotinylated Mouse Monoclonal Antibody to Pembrolizumab (Clone : 10E12C6) | 45-1084 |
Rabbit Polyclonal Antibody to Pembrolizumab | 45-1085 |
Mouse Monoclonal Antibody to Nivolumab (Clone : 8G6G3D8) | 45-1086 |
Biotinylated Mouse Monoclonal Antibody to Nivolumab (Clone : 6G5H2E6) | 45-1087 |
Biotinylated Rabbit Monoclonal Antibody to Pembrolizumab (Clone : 90G12F8) | 45-1088 |
Biotinylated Mouse Monoclonal Antibody to Ipilimumab (Clone : 4H6E1D4) | 45-1090 |
Mouse Monoclonal Antibody to Ipilimumab (Clone : 26B6H7D9) | 45-1091 |
Rabbit Polyclonal Antibody to Adalimumab/Humira | 45-1111 |
Rabbit polyclonal Antibody to Bevacizumab/Avastin | 45-1112 |
Rabbit Monoclonal Antibody to Bevacizumab/Avastin (Clone : 30E1) | 45-1116 |
Biotinylated Rabbit Monoclonal Antibody to Bevacizumab/Avastin (Clone : 46E3) | 45-1117 |
Rabbit Polyclonal Antibody to Rituximab /Rituxan | 45-1118 |